These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 18758459)
1. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Lee Y; Samaco RC; Gatchel JR; Thaller C; Orr HT; Zoghbi HY Nat Neurosci; 2008 Oct; 11(10):1137-9. PubMed ID: 18758459 [TBL] [Abstract][Full Text] [Related]
2. Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1. Ju H; Kokubu H; Lim J Mol Neurobiol; 2014 Dec; 50(3):866-874. PubMed ID: 24752589 [TBL] [Abstract][Full Text] [Related]
4. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Lim J; Crespo-Barreto J; Jafar-Nejad P; Bowman AB; Richman R; Hill DE; Orr HT; Zoghbi HY Nature; 2008 Apr; 452(7188):713-8. PubMed ID: 18337722 [TBL] [Abstract][Full Text] [Related]
5. Altered Purkinje cell miRNA expression and SCA1 pathogenesis. Rodriguez-Lebron E; Liu G; Keiser M; Behlke MA; Davidson BL Neurobiol Dis; 2013 Jun; 54():456-63. PubMed ID: 23376683 [TBL] [Abstract][Full Text] [Related]
6. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. Crespo-Barreto J; Fryer JD; Shaw CA; Orr HT; Zoghbi HY PLoS Genet; 2010 Jul; 6(7):e1001021. PubMed ID: 20628574 [TBL] [Abstract][Full Text] [Related]
7. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Duvick L; Barnes J; Ebner B; Agrawal S; Andresen M; Lim J; Giesler GJ; Zoghbi HY; Orr HT Neuron; 2010 Sep; 67(6):929-35. PubMed ID: 20869591 [TBL] [Abstract][Full Text] [Related]
8. SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis. Orr HT Prog Neurobiol; 2012 Dec; 99(3):179-85. PubMed ID: 22531670 [TBL] [Abstract][Full Text] [Related]
9. The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1. Venkatraman A; Hu YS; Didonna A; Cvetanovic M; Krbanjevic A; Bilesimo P; Opal P Hum Mol Genet; 2014 Jul; 23(14):3733-45. PubMed ID: 24594842 [TBL] [Abstract][Full Text] [Related]
10. Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1. Ju H; Kokubu H; Todd TW; Kahle JJ; Kim S; Richman R; Chirala K; Orr HT; Zoghbi HY; Lim J J Neurosci; 2013 May; 33(22):9328-36. PubMed ID: 23719801 [TBL] [Abstract][Full Text] [Related]
11. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. Zoghbi HY; Orr HT J Biol Chem; 2009 Mar; 284(12):7425-9. PubMed ID: 18957430 [TBL] [Abstract][Full Text] [Related]
12. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice. Clark HB; Orr HT J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181 [TBL] [Abstract][Full Text] [Related]
13. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy. Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195 [TBL] [Abstract][Full Text] [Related]
14. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986 [TBL] [Abstract][Full Text] [Related]
15. Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model. Gehrking KM; Andresen JM; Duvick L; Lough J; Zoghbi HY; Orr HT Hum Mol Genet; 2011 Jun; 20(11):2204-12. PubMed ID: 21427130 [TBL] [Abstract][Full Text] [Related]
16. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product. Hong S; Kim SJ; Ka S; Choi I; Kang S Mol Cell Neurosci; 2002 Jun; 20(2):298-306. PubMed ID: 12093161 [TBL] [Abstract][Full Text] [Related]
17. Progress in pathogenesis studies of spinocerebellar ataxia type 1. Cummings CJ; Orr HT; Zoghbi HY Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309 [TBL] [Abstract][Full Text] [Related]
18. Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model. Hearst SM; Shao Q; Lopez M; Raucher D; Vig PJ Cerebellum; 2014 Oct; 13(5):596-606. PubMed ID: 24930030 [TBL] [Abstract][Full Text] [Related]
19. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes. Bowman AB; Lam YC; Jafar-Nejad P; Chen HK; Richman R; Samaco RC; Fryer JD; Kahle JJ; Orr HT; Zoghbi HY Nat Genet; 2007 Mar; 39(3):373-9. PubMed ID: 17322884 [TBL] [Abstract][Full Text] [Related]
20. Direct and accurate measurement of CAG repeat configuration in the ataxin-1 (ATXN-1) gene by "dual-fluorescence labeled PCR-restriction fragment length analysis". Lin JX; Ishikawa K; Sakamoto M; Tsunemi T; Ishiguro T; Amino T; Toru S; Kondo I; Mizusawa H J Hum Genet; 2008; 53(4):287-295. PubMed ID: 18301861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]